Department of Pathology
Brigham and Women's Hospital
A teaching Affliate of Harvard Medical School
 

Name and Present Position:

JEFFERY L. KUTOK, Pathologist

Address:

Brigham and Women's Hospital, 75 Francis Street, Thorn Building Rm 612A, Boston, MA

Medical School (including school name, date and degree awarded):

1993 PhD, State University of New York at Stony Brook, Stony Brook, NY
1995 MD, State University of New York School of Medicine at Stony Brook
  Graduate Medical Education (including dates and institution of internships, residencies, fellowships, etc.):

1995-1997 Resident in Anatomic Pathology, Brigham and Women's Hospital
1997-1998 Fellow in Hematopathology, Brigham and Women's Hospital
1/98-3/98 Chief Resident in Pathology, Brigham and Women's Hospital
1998-2000 Research Fellow in Pathology, Brigham and Women's Hospital

Certification:

2000 American Board of Pathology (Anatomic Pathology and Hematology)

Current Academic Appointment:

Associate Professor of Pathology, Harvard Medical School, Boston, MA

Current Medical Staff Appointment(s):

Pathologist, Brigham and Women's Hospital
Pathologist, Specialized Histopathology Core, Dana-Farber Harvard Cancer Center, Boston, MA

Selected Bibliography:

  • Juszczynski P, Kutok JL, Li C, Mitra J, Aguiar RC, Shipp MA. BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate. Mol Cell Biol. 2006;26(14):5348-59.
  • Rodig SJ, Abramson JS, Pinkus GS, Treon SP, Dorfman DM, Dong HY, Shipp MA, Kutok JL. Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H).Clin Cancer Res. 2006 1;12(23):7174-9.
  • Rodig SJ , Healey BM, Pinkus GS, Kuo FC, Dal Cin P, Kutok JL. Mantle Cell Lymphoma Arising Within Primary Nodal Marginal Zone Lymphoma: A Unique Presentation Of Two Uncommon B Cell Lymphoproliferative Disorders. Cancer Genetics and Cytogenetics 2006;171(1):44-51.
  • Robertson MJ, Kahl BS, Vose JM, de Vos S, Laughlin M, Flynn PJ, Rowland K, Cruz JC, Goldberg SL, Musib L, Darstein C, Enas N, Kutok JL, et al. Phase II Study of Enzastaurin, a Protein Kinase C Beta Inhibitor, in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma. J Clin Oncol. 2007 Mar 26; [Epub ahead of print]
  • Rodig SJ, Savage KJ, LaCasce AS, Weng AP, Harris NL, Shipp MA, Hsi ED, Gascoyne RD, Kutok JL. Expression of TRAF1 and Nuclear c-Rel Distinguishes Primary Mediastinal Large Cell Lymphoma from Other Types of Diffuse Large B Cell Lymphoma. Am J Surg Path. 2007 Jan;31(1):106-12.
  • Shepard JL, Amatruda JF, Finkelstein D, Ziai J, Finley KR, Stern HM, Chiang K, Hersey C, Barut B, Freeman JL, Lee C, Glickman JN, Kutok JL, Aster JC, Zon LI. A mutation in separase causes genome instability and increased susceptibility to epithelial cancer. Genes Dev. 2007 Jan 1;21(1):55-9.
  • Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K. Regulation of the germinal center response by microRNA-155. Science. 2007 Apr 27;316(5824):604-8.
  • Zangani MM, Froyland M, Qiu GY, Meza-Zepeda LA, Kutok JL, Thompson KM, Munthe LA, Bogen B. Lymphomas can develop from B cells chronically helped by idiotype-specific T cells. J Exp Med. 2007 May 14;204(5):1181-91
  • Gill MB, Kutok JL, Fingeroth JD. EBVTK is a centrosomal resident precisely localized to the periphery of centrioles. J Virol. 2007 Apr 11; [Epub ahead of print]
  • Kutok JL and Wang F. EBV Spectrum of Disease. Annual Review of Pathology: Mechanisms of Disease 2006, Vol. 1: Page 375 - 404. A. Abbas, J Downing, V., Kumar eds.
  • Kutok JL. Tumors of the Hemopoietic System. In: Fletcher CDM, ed. Diagnostic Histopathology of Tumors. Churchill Livingstone 3rd edition 2007